
3
Total Mentions
3
Documents
0
Connected Entities
HOUSE_OVERSIGHT_024003 - HOUSE_OVERSIGHT_024116
roles and have been founding investors in a number of successful start-up companies. These have included Pearl Therapeutics (NLV-I, exited in sale to Astra Zeneca, 2.5x multiple plus milestones), Relypsa (NLV-I,_ private initially, now public on NASDAQ: RLYP), Convergence/Calchan Pharmaceuticals (NLV-IL, one st
Page: HOUSE_OVERSIGHT_024045 →YAHOO_002028
and would address them "in the appropriate forum."AstraZeneca (AZN) lost its bid for a temporary restraining or
1e6e0B6ef701fe">Italy and France ready to restart AstraZeneca vaccinations if regulators OK them</a> (CNBC)<br/
No connected entities